RIFAXIMIN IN THE TREATMENT AND PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE: A META-ANALYSIS

被引：0
|
作者：
Kimer, N. [1 ]
Gluud, L. L. [2 ]
Moller, S. [3 ]
Bendtsen, F. [1 ]
Krag, A. [1 ]
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark
[2] Univ Copenhagen, Gentofte Hosp, Dept Internal Med, Gentofte, Denmark
[3] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct & Diagnost Imaging & Res, DK-2650 Hvidovre, Denmark
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60208-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
206
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of rifaximin in the treatment of hepatic encephalopathy in liver cirrhosis.
    Lata, J
    Hulek, P
    Spicak, J
    Fejfar, T
    Drastich, P
    Marecek, Z
    Bruha, R
    Husova, L
    Senkyrik, M
    HEPATOLOGY, 2002, 36 (04) : 519A - 519A
  • [32] Comparison of Efficacy of Rifaximin and Non-Absorbable Disaccharides in Management of Hepatic Encephalopathy: A Meta-Analysis
    Shukla, Sandhya
    Mehboob, Shahid
    Guha, Sushovan
    GASTROENTEROLOGY, 2011, 140 (05) : S955 - S955
  • [33] Mean Blood Ammonia Level After Treatment With Rifaximin Versus Neomycin In Chronic Liver Disease Patients Presenting With Hepatic Encephalopathy
    Mumtaz, Sami Ullah
    Iqtadar, Somia
    Niaz, Zafar
    Komal, Tayyeba
    Abaidullah, Sajid
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2019, 25 (01): : 37 - 40
  • [34] RIFAXIMIN IS EFFICACIOUS IN THE TREATMENT OF CHRONIC OVERT HEPATIC ENCEPHALOPATHY: A UK LIVER MULTI-CENTRE EXPERIENCE
    Patel, V. C.
    Orr, J.
    Sturgeon, J.
    Habtemariam, Z.
    Preedy, H.
    Richardson, P.
    Aspinall, R.
    Hudson, M.
    Shawcross, D. L.
    GUT, 2014, 63 : A14 - A15
  • [35] COST EFFECTIVENESS ANALYSIS OF RIFAXIMIN FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY
    Rivas, R.
    Cerezo, O.
    Zapata, L.
    VALUE IN HEALTH, 2010, 13 (03) : A73 - A73
  • [36] Meta-analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy
    Zhou, Yu-Lian
    Pu, Shu-Tao
    Xiao, Jian-Bo
    Luo, Jun
    Xue, Li
    LIVER INTERNATIONAL, 2024, 44 (12) : 3164 - 3173
  • [37] Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
    Tantai, Xin-Xing
    Yang, Long-Bao
    Wei, Zhong-Cao
    Xiao, Cai-Lan
    Chen, Li-Rong
    Wang, Jin-Hai
    Liu, Na
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (21) : 2683 - 2698
  • [38] Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
    Xin-Xing Tantai
    Long-Bao Yang
    Zhong-Cao Wei
    Cai-Lan Xiao
    Li-Rong Chen
    Jin-Hai Wang
    Na Liu
    World Journal of Gastroenterology, 2019, (21) : 2683 - 2698
  • [39] Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis
    Fang, Guihua
    Liu, Shuna
    Liu, Bin
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [40] Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis
    Guihua Fang
    Shuna Liu
    Bin Liu
    BMC Gastroenterology, 24
12345